• Celularity regained compliance with Nasdaq's periodic reporting requirement on Oct. 22, 2026, closing the last of three previously disclosed deficiency matters.
• The determination followed its Oct. 20, 2026, Form 10-Q filing for the quarter ended June 30, 2026.
• Nasdaq previously closed minimum bid price and minimum market value of listed securities deficiencies on Sept. 11, 2026.
• Management has begun overhauling the finance organization to address recurring reporting delays.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610220800PRIMZONEFULLFEED9850962) on October 22, 2026, and is solely responsible for the information contained therein.